Aimax Bhd (XKLS:0041) Research & Development: RM0.00 Mil (TTM As of Sep. 2025)


What is Aimax Bhd Research & Development?

Aimax Bhd XKLS:0041 Research & Development is RM0.00 Mil as of Sep. 2025. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Aimax Bhd's Research & Development for the three months ended in Sep. 2025 was RM0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was RM0.00 Mil.

Aimax Bhd  (XKLS:0041) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aimax Bhd Research & Development Related Terms

Aimax Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for Aimax Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aimax Bhd Research & Development Chart

Aimax Bhd Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Mar19 Mar20 Sep22 Sep23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aimax Bhd Quarterly Data
Mar20 Jun20 Sep20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aimax Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0.00 Mil mean?
Aimax Bhd (XKLS:0041) has a Research & Development of RM0.00 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on Aimax Bhd and its competitors.
Is Aimax Bhd's Research & Development too high?
Aimax Bhd's current Research & Development is RM0.00 Mil.
How does Aimax Bhd's Research & Development compare to HON and MMM?
Aimax Bhd's Research & Development of RM0.00 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Conglomerates company?
A good Research & Development depends on the Conglomerates industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aimax Bhd and its competitors. Aimax Bhd's current Research & Development is RM0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimax Bhd stock overvalued right now?
Based on GuruFocus' analysis, Aimax Bhd (XKLS:0041) is currently considered Fairly Valued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.01 — trading right at its estimated fair value. The current Research & Development is RM0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aimax Bhd (XKLS:0041), the current Research & Development is RM0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aimax Bhd Business Description

Address C-01-3, Block C Plaza Glomac, No 6, Jalan SS7/19, Kelana Jaya, Petaling Jaya, SGR, MYS, 47301
Aimax Bhd, formerly known as Hong Seng Consolidated Bhd, is operating as an investment holding company. The company operates in four operating segments. The healthcare segment consists of a medical diagnostic and research laboratory and wholesale of pharmaceutical and medical goods; the Financial services include Moneylending; the Gloves segment consists of Manufacturing and trading of rubber gloves; and Seafood segment which consists of Trading of Seafood products. The majority of the revenue is derived from the healthcare segment.